NPs Basic Information

Name
(2Z,3E,5E,7E,9E,11E,13E)-2-(2,4-dimethylhexylidene)-14-[4-hydroxy-6-oxo-5-[(2S,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]pyran-2-yl]-4-methyltetradeca-3,5,7,9,11,13-hexaenoic acid
Molecular Formula C34H44O10
IUPAC Name*
(2Z,3E,5E,7E,9E,11E,13E)-2-(2,4-dimethylhexylidene)-14-[4-hydroxy-6-oxo-5-[(2S,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]pyran-2-yl]-4-methyltetradeca-3,5,7,9,11,13-hexaenoic acid
SMILES
CCC(C)CC(C)/C=C(/C=C(\C)/C=C/C=C/C=C/C=C/C=C/C1=CC(=C(C(=O)O1)[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)\C(=O)O
InChI
InChI=1S/C34H44O10/c1-5-21(2)16-23(4)18-24(33(40)41)17-22(3)14-12-10-8-6-7-9-11-13-15-25-19-26(36)28(34(42)43-25)32-31(39)30(38)29(37)27(20-35)44-32/h6-15,17-19,21,23,27,29-32,35-39H,5,16,20H2,1-4H3,(H,40,41)/b7-6+,10-8+,11-9+,14-12+,15-13+,22-17+,24-18-/t21?,23?,27-,29+,30+,31-,32+/m1/s1
InChIKey
YQULWNMZEPTDEC-KZQZVYFXSA-N
Synonyms
CHEMBL2016579; D8646-2-6
CAS NA
PubChem CID 56832636
ChEMBL ID CHEMBL2016579
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Prenol lipids
        • Subclass: Terpene lactones
          • Direct Parent: Terpene lactones

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte IDEndophyte NameFamilyGenusTaxonomy IDGenBank IDClosest GenBank IDReference
Endophyte ID
Endophyte Name
Family
Genus
Taxonomy ID
GenBank ID
Closest GenBank ID
Reference
Endophyte ID
Endophyte Name
Family
Genus
Taxonomy ID
GenBank ID
Closest GenBank ID
Reference
Loading...
Endophyte IDEndophyte NameFamilyGenusTaxonomy IDGenBank IDClosest GenBank IDReference
Showing 0 to 0 of 0 entries

NPs Physi-Chem Properties

Molecular Weight: 612.7 ALogp: 5.2
HBD: 6 HBA: 10
Rotatable Bonds: 14 Lipinski's rule of five: Rejected
Polar Surface Area: 174.0 Aromatic Rings: 2
Heavy Atoms: 44 QED Weighted: 0.127

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.581 MDCK Permeability: 0.00000478
Pgp-inhibitor: 0.001 Pgp-substrate: 0.774
Human Intestinal Absorption (HIA): 0.935 20% Bioavailability (F20%): 0.95
30% Bioavailability (F30%): 0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.016 Plasma Protein Binding (PPB): 88.18%
Volume Distribution (VD): 0.737 Fu: 3.88%

ADMET: Metabolism

CYP1A2-inhibitor: 0.468 CYP1A2-substrate: 0.025
CYP2C19-inhibitor: 0.182 CYP2C19-substrate: 0.058
CYP2C9-inhibitor: 0.731 CYP2C9-substrate: 0.995
CYP2D6-inhibitor: 0.524 CYP2D6-substrate: 0.918
CYP3A4-inhibitor: 0.085 CYP3A4-substrate: 0.053

ADMET: Excretion

Clearance (CL): 0.543 Half-life (T1/2): 0.682

ADMET: Toxicity

hERG Blockers: 0.211 Human Hepatotoxicity (H-HT): 0.884
Drug-inuced Liver Injury (DILI): 0.968 AMES Toxicity: 0.031
Rat Oral Acute Toxicity: 0.35 Maximum Recommended Daily Dose: 0.94
Skin Sensitization: 0.943 Carcinogencity: 0.288
Eye Corrosion: 0.003 Eye Irritation: 0.01
Respiratory Toxicity: 0.835
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

*Note: the compound similarity was calculated by RDKIT.